X-ABT - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $98,030.59 -1.04%
Ethereum $3,423.41 +3.71%
BNB $658.23 +5.43%
Optimism $2.22 +4.32%
Arbitrum $0.87 +10.40%
Solana $256.94 +0.84%
Polygon $0.58 +21.21%
Cosmos $8.22 +11.59%
Avalanche $42.15 +6.34%

Bitcoin $98,030.59 -1.04%
Ethereum $3,423.41 +3.71%
BNB $658.23 +5.43%
Optimism $2.22 +4.32%
Arbitrum $0.87 +10.40%
Solana $256.94 +0.84%
Polygon $0.58 +21.21%
Cosmos $8.22 +11.59%
Avalanche $42.15 +6.34%

X-ABT

company

Summary
Funding Rounds
Investors

About

X-ABT is a diagnostic enterprise specialized in the development of detection solutions for pathogenic microbes.

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: ¥20M
Industries: Biotechnology,Health Care,Medical
Founded date: May 27, 2010
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

¥70M

X-ABT has raised a total of ¥70M in funding over 2 rounds. Their latest funding was raised on Mar 24, 2020 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 24, 2020	Series B	¥50M	1	—	—	Detail
Apr 5, 2017	Post-IPO Equity	¥20M	2	—	—	Detail
Jun 30, 2016	Series Unknown	—	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

4

X-ABT is funded by 4 investors. Wancheng Ziben Guanli (Beijing) Youxian Gongsi and Suzhou Gongye Yuanqu Wan Cheng Jiuzhou Touzi Zhongxin (Youxian Hehuo) are the most recent investors.

Investor Name	Lead Investor	Funding Round
Wancheng Ziben Guanli (Beijing) Youxian Gongsi	—	Series B
Suzhou Gongye Yuanqu Wan Cheng Jiuzhou Touzi Zhongxin (Youxian Hehuo)	—	Post-IPO Equity
Ningbo Meishan Baoshui Gangqu Wancheng Dacheng Touzi Guanli Hehuo Qiye (Youxian Hehuo)	—	Post-IPO Equity
JC Capital	—	Series Unknown